MATHIEU, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 335.232
NA - Nord America 18.542
AS - Asia 6.681
SA - Sud America 1.265
Continente sconosciuto - Info sul continente non disponibili 730
AF - Africa 149
OC - Oceania 16
Totale 362.615
Nazione #
IT - Italia 330.280
US - Stati Uniti d'America 18.217
SG - Singapore 2.504
CN - Cina 2.368
UA - Ucraina 1.171
NL - Olanda 1.104
BR - Brasile 959
SE - Svezia 707
VN - Vietnam 688
FI - Finlandia 499
DE - Germania 433
GB - Regno Unito 386
FR - Francia 331
HK - Hong Kong 199
CA - Canada 178
IN - India 154
KR - Corea 122
BD - Bangladesh 118
AR - Argentina 106
TR - Turchia 73
IQ - Iraq 71
JP - Giappone 71
RU - Federazione Russa 64
ID - Indonesia 57
CO - Colombia 56
MX - Messico 46
ES - Italia 40
EC - Ecuador 38
BE - Belgio 35
PL - Polonia 31
VE - Venezuela 29
ZA - Sudafrica 29
IL - Israele 28
PK - Pakistan 27
CL - Cile 24
MA - Marocco 23
TN - Tunisia 23
UZ - Uzbekistan 23
IR - Iran 22
SA - Arabia Saudita 20
AT - Austria 18
EG - Egitto 18
JM - Giamaica 17
PH - Filippine 17
PY - Paraguay 16
CH - Svizzera 15
GR - Grecia 15
JO - Giordania 15
PE - Perù 15
CZ - Repubblica Ceca 14
KE - Kenya 13
TT - Trinidad e Tobago 13
BO - Bolivia 12
CR - Costa Rica 12
HN - Honduras 12
IE - Irlanda 12
AU - Australia 11
DK - Danimarca 11
DZ - Algeria 11
ET - Etiopia 11
OM - Oman 11
NP - Nepal 10
GT - Guatemala 9
UY - Uruguay 8
AZ - Azerbaigian 7
BG - Bulgaria 7
BY - Bielorussia 7
HR - Croazia 7
LT - Lituania 7
MY - Malesia 7
PS - Palestinian Territory 7
KG - Kirghizistan 6
KZ - Kazakistan 6
PR - Porto Rico 6
TH - Thailandia 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
DO - Repubblica Dominicana 5
LB - Libano 5
LU - Lussemburgo 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
BB - Barbados 4
EE - Estonia 4
EU - Europa 4
LC - Santa Lucia 4
LK - Sri Lanka 4
LV - Lettonia 4
MU - Mauritius 4
NO - Norvegia 4
PT - Portogallo 4
RO - Romania 4
SC - Seychelles 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BZ - Belize 3
CW - ???statistics.table.value.countryCode.CW??? 3
GE - Georgia 3
Totale 361.846
Città #
Cagliari 208.249
Uta 120.956
Ashburn 2.080
Fairfield 1.540
Woodbridge 1.338
Singapore 1.162
Amsterdam 1.072
San Jose 1.013
Chandler 921
Houston 900
Dallas 888
Ann Arbor 768
Boardman 726
Wilmington 647
Jacksonville 614
Seattle 559
Cambridge 494
Nyköping 462
Beijing 414
Dearborn 377
Council Bluffs 348
Helsinki 303
Los Angeles 289
Santa Clara 214
Nanjing 208
Lauterbourg 199
Hefei 189
Ho Chi Minh City 183
Boston 182
The Dalles 181
Hong Kong 180
New York 164
Buffalo 163
Shanghai 146
Dong Ket 128
Hanoi 121
Milan 121
São Paulo 113
Seoul 112
San Diego 88
Redwood City 86
Shenyang 83
Toronto 77
Rome 76
Guangzhou 74
Nanchang 72
Chicago 63
Phoenix 62
London 59
Hebei 52
Tianjin 52
Jiaxing 48
Changsha 46
Tokyo 46
Washington 46
Munich 45
Princeton 45
Columbus 43
Mountain View 42
Verona 38
Brooklyn 36
Sassari 35
Belo Horizonte 33
Atlanta 32
North Bergen 32
Norwalk 32
Baghdad 31
Istanbul 31
Jinan 31
Orange 30
Redondo Beach 30
Frankfurt am Main 28
Brussels 26
Nuremberg 26
San Francisco 26
Orem 25
Auburn Hills 23
Da Nang 23
Falls Church 23
Montreal 23
Warsaw 23
Denver 22
Kunming 21
Tashkent 21
Zhengzhou 21
Haiphong 20
Rio de Janeiro 20
San Mateo 20
Chennai 19
Stockholm 19
Detroit 18
Dhaka 17
Hải Dương 17
Mumbai 17
Brasília 16
Buenos Aires 16
Florence 16
Pune 16
Santiago 16
Ningbo 15
Totale 350.913
Nome #
Telemedicine applied to kinesiotherapy for hand dysfunction in patients with systemic sclerosis and rheumatoid arthritis: recovery of movement and telemonitoring technology 118.838
FRI0357 DRUG-INDUCED REMISSION AND SUBCLINICAL ACTIVITY IN PSORIATIC ARTHRITIS: TRANSCRIPTIONAL PROFILING TO CHARACTERIZE THE DISEASE STATE 10.769
Overexpression of the cytokine BAFF and autoimmunity risk 4.154
An optimized infrastructure for deferred telemonitoring of home rehabilitation in chronic rheumatic patients 3.955
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 3.204
Home tele-rehabilitation for rheumatic patients: impact and satisfaction of care analysis 3.111
Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis 3.084
Physician's global assessment in psoriatic arthritis: A multicenter GRAPPA study 3.055
Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus 2.921
Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001–2012 2.852
AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population 2.844
Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001-2012 2.823
Apparatus, a system and a relating method for local or remote rehabilitation and functional evaluation of the hands 2.693
Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study 2.637
Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series 2.631
A Device for Local or Remote Monitoring of Hand Rehabilitation Sessions for Rheumatic Patients 2.628
Physical activity levels and health-related quality of life in young Italian population 2.429
Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study 2.378
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus 2.358
Prevalence and determinants of peripheral microvascular endothelial dysfunction in rheumatoid arthritis patients: a multicenter cross-sectional study 2.355
An allelic variant in the intergenic region between ERAP1 and ERAP2 correlates with an inverse expression of the two genes 2.305
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: An alternative to standard of care 2.295
Polymyalgia rheumatica: an autoinflammatory disorder? 2.250
null 2.245
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 2.222
PET/CT scan revealing active idiopathic inflammatory myopathy with normal serum sarcoplasmic enzymes levels 2.199
Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis 2.198
Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests 2.191
The rs75862629 minor allele in the endoplasmic reticulum aminopeptidases intergenic region affects human leucocyte antigen B27 expression and protects from ankylosing spondylitis in Sardinia 2.152
An Integrated Portable Device for the Hand Functional Assessment in the Clinical Practice 2.124
Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus 2.121
Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis) 2.107
Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review 2.090
Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort 2.045
The ankylosing spondylitis-associated HLA-B*2705 presents a B*0702-restricted EBV epitope and sustains the clonal amplification of cytotoxic T cells in patients 2.000
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09 1.983
Re: Ultrasound Findings on Hands and Wrists of Patients with Systemic Lupus Erythematosus: Relationship with Physical Examination 1.968
Ankylosing spondylitis: A trade off of HLA-B27, ERAP, and pathogen interconnections? Focus on Sardinia 1.964
Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time 1.948
Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease 1.947
Pachidermoperiostosis as a cause of massive joint effusion with polyarticular involvement mimicking juvenile idiopathic arthritis: A case report 1.929
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 1.870
Unusual Placement of an EBV Epitope into the Groove of the Ankylosing Spondylitis-Associated HLA-B27 Allele Allows CD8+ T Cell Activation 1.827
A portable real-time monitoring system for kinesitherapic hand rehabilitation exercises 1.820
Rituximab treatment for 'rhupus syndrome': clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study 1.807
null 1.791
New approaches in tumor necrosis factor antagonism for the treatment of psoriatic arthritis: certolizumab pegol 1.710
Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia : Implications for disease pathogensis 1.688
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 1.679
Does subclinical atherosclerosis really exist in systemic sclerosis? Comment on the article by Turiel et al. 1.670
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI) 1.656
QT and QT dispersion intervals in long-standing and moderately active rheumatoid arthritis: results from a multicentre cross-sectional study 1.639
Treatment target in newly diagnosed systemic lupus erythematosus: The association of lupus low disease activity state and remission with lower accrual of early damage 1.624
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study 1.620
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 1.610
null 1.562
Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up study 1.516
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 1.515
Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients 1.495
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 1.492
Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology 1.484
Genetics of Behcet's disease in Sardinia: two distinct extended HLA haplotypes harbour the B*51 allele in the normal population and in patients 1.477
Genetics of seronegative spondyloarthritis, susceptibility and aetiopathogenesis: A single centre experience 1.466
null 1.431
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 1.415
Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset 1.376
Comparison of early vs. delayed anakinra treatment in patients with adult onset still's disease and effect on clinical and laboratory outcomes 1.344
Clinical profile and direct medical cost of care of adults presenting with systemic lupus erythematosus in Italy 1.323
Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study 1.279
The growing role of cardiac magnetic resonance imagin in assessment and follow-up of pulmonary arterial hypertension associated with systemic sclerosis 1.264
Early disease and low baseline damage as predictors of response to belimumab in patients with systemic lupus erythematosus in a real-life setting 1.258
null 1.241
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 1.231
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort 1.201
Vitamin D levels and potential impact in systemic sclerosis 1.152
Association between the presence of c-ANCA and abnormal cerebral single photon emission computed tomography (SPECT) in patients with systemic lupus erythematosus 1.146
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.091
Global microRNA profiling of peripheral blood mononuclear cells in patients with Behçet's disease 1.091
The origin of Behçet’s disease geoepidemiology: possible role of a dual microbial - driven genetic selection. 1.083
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 1.082
Post-Streptococcal Reactive Arthritis Associated With Group G Streptococcal Pharyngitis 1.054
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNF-alpha agents in axial spondyloarthritis 1.022
Multiple Septic Bursitis and Spontaneous Achilles Tendon Tear in Systemic Lupus Erythematosus 1.013
Hemarthrosis as acute presentation of acquired hemophilia in a patient with systemic lupus erythematosus: successful treatment and long-lasting remission 1.008
Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis 1.007
Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice 1.004
Physical Activity Levels And Health-related Quality Of Life In Italian University Students 986
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review 953
HLA-B*2709 and lack of susceptibility to sacroiliitis: further support from the clinic 928
Circulating antibodies to DNA-related antigens in patients with autoimmune thyroid disorders. 921
Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis: comment on the article by Mok et al 910
Organ damage is a major determinant of work productivity impairment in Behçet's Syndrome: a post-hoc analysis of the BODI validation study 902
null 902
Two different clinical subsets of lupus hepatitis exist. Mimicking primary autoimmune liver diseases or part of their spectrum? 902
Calcitonin decreases lithium plasma levels in man. Preliminary report 898
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 873
Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian study 872
Familial chilblain and late contractural arachnodactyly: A novel association? 868
A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B*2705 in Sardinia 864
Psoriatic arthritis: genetics and pathogenesis 851
Totale 301.766
Categoria #
all - tutte 461.467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 461.467


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.364 0 0 0 0 911 893 729 683 1.203 1.008 1.486 1.451
2022/202316.051 1.637 1.842 1.641 1.235 1.471 1.550 715 2.097 1.095 926 1.127 715
2023/202423.751 1.187 772 885 1.656 2.156 3.234 3.323 3.923 982 1.467 2.304 1.862
2024/2025162.043 10.164 11.446 7.398 120.906 2.504 2.417 3.913 251 477 1.522 450 595
2025/202612.458 652 706 1.532 1.302 939 849 1.780 1.748 897 1.013 716 324
2026/20273.312 495 483 964 1.188 182 0 0 0 0 0 0 0
Totale 362.615